Utah Medical Products, Inc.
UTMD
$63.12
$0.250.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 38.52M | 38.63M | 38.83M | 39.27M | 40.90M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 38.52M | 38.63M | 38.83M | 39.27M | 40.90M |
| Cost of Revenue | 16.52M | 16.57M | 16.57M | 16.36M | 16.76M |
| Gross Profit | 22.00M | 22.06M | 22.26M | 22.92M | 24.14M |
| SG&A Expenses | 8.57M | 8.27M | 7.71M | 7.65M | 7.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.76M | 25.42M | 24.86M | 24.71M | 25.17M |
| Operating Income | 12.76M | 13.21M | 13.97M | 14.56M | 15.73M |
| Income Before Tax | 14.11M | 14.62M | 15.49M | 15.86M | 16.80M |
| Income Tax Expenses | 2.82M | 3.00M | 2.93M | 2.90M | 2.93M |
| Earnings from Continuing Operations | 11.29 | 11.62 | 12.55 | 12.96 | 13.87 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.29M | 11.62M | 12.55M | 12.96M | 13.87M |
| EBIT | 12.76M | 13.21M | 13.97M | 14.56M | 15.73M |
| EBITDA | 15.71M | 16.13M | 16.86M | 17.40M | 18.53M |
| EPS Basic | 3.48 | 3.53 | 3.74 | 3.78 | 3.95 |
| Normalized Basic EPS | 2.98 | 3.03 | 3.13 | 3.20 | 3.37 |
| EPS Diluted | 3.48 | 3.53 | 3.74 | 3.78 | 3.95 |
| Normalized Diluted EPS | 2.98 | 3.03 | 3.13 | 3.20 | 3.37 |
| Average Basic Shares Outstanding | 12.96M | 13.15M | 13.42M | 13.71M | 14.02M |
| Average Diluted Shares Outstanding | 12.96M | 13.15M | 13.42M | 13.71M | 14.02M |
| Dividend Per Share | 1.23 | 1.22 | 1.22 | 1.21 | 1.21 |
| Payout Ratio | 35.29% | 34.80% | 32.72% | 32.32% | 30.70% |